Smart Stocks Watch: Ampio Pharmaceuticals — Sexual Dysfunction, Ophthalmology, Nephrology

Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a clinical-stage biopharmaceutical company developing drugs for sexual dysfunction, inflammatory diseases and ophthalmological conditions has announced a manufacturing agreement with drug delivery maker Enthypharm Ltd for Zertane, Ampio’s drug for the treatment of premature ejaculation (PE).

Read more »

Newly Launched NICE Quality Standards For CKD Form Framework For Health Care Professionals

Kidney disease is more common than people might think. The bean shaped organs responsible for a host of functions cause havoc when things go awry.

Read more »